Searched for
FY25 REVENUE ESTIMATE
ET Prime Special Series: Multibagger or IBC - Part 64: An old 2-wheeler supplier that now earns more from a newer businessAt first glance, this auto ancillary company looks like a conventional two-wheeler supplier. But its business mix tells a wider story. A ne...- CSM Technologies IPO Day 2 update: Subscribed 32%, GMP at 4%. Should you subscribe?CSM Technologies' IPO is seeing a subdued response on its second day, with only 32% subscription. Retail investors show more interest, subs...
- Buy, Sell or Hold: Goldman Sachs maintains sell on Bharat Dynamics; HDFC Securities maintains buy on IndiaMART InterMESHBrokerages remain divided on two stocks. Goldman Sachs retained its 'Sell' rating on Bharat Dynamics, raising the target price marginally t...
- Trent shares jump 4% after Noel Tata’s comments during AGM. Here’s what Morgan Stanley, other brokerages sayTrent's stock surged over 4% as brokerages like Morgan Stanley and Motilal Oswal reiterated bullish calls. Chairman Noel Tata's vision of 1...
- Tata Motors shares jump 5% on strong growth guidance. What are Nomura, other brokerages saying?Tata Motors shares rose after outlining strong growth targets, including margin expansion and cash flow improvement. Brokerages remain divi...
- Nomura cuts target price of this AI, data centre beneficiary company. Here’s whyNomura remains positive on Anant Raj despite trimming earnings estimates and lowering its target price due to slower cloud ramp-up and proj...
- The Adani stock Morgan Stanley thinks could benefit most from India’s infrastructure pushMorgan Stanley has initiated coverage on Adani Enterprises with an Overweight rating and a target price of Rs 3,638, implying a 23% upside....
- Buy, Sell or Hold: Morgan Stanley remains overweight on Trent; Citi maintains buy on BELBrokerages are bullish on select retail, defence, and auto stocks, citing strong growth prospects. Morgan Stanley backs Trent's aggressive ...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Advit Jewels IPO opens: Check brokerage review, GMP, subscription and other detailsAdvit Jewels' IPO opened with significant investor enthusiasm, evidenced by a 40% grey market premium. The Jaipur-based jewellery maker aim...
- Bharti Airtel raises stake in Airtel Africa to 79 per cent in transaction worth Rs 28,000 crBharti Airtel has significantly boosted its stake in Airtel Africa to approximately 79 percent through a Rs 28,200 crore share-swap deal. T...
- Jefferies initiates coverage on GE Vernova, bullish on 2 other power transmission stocksJefferies has initiated coverage on GE Vernova T&D India with a Hold rating and a target price of ₹6,000, citing limited upside despite str...
- Buy, Sell or Hold: Citi initiates buy on Meesho; Elara Capital recommends buy on Mahindra LogisticsBrokerages are selectively backing consumer, logistics, and e-commerce firms with strong growth prospects. Citi initiates coverage on Meesh...
- Bharat Electronics shares in focus after defence PSU wins orders worth Rs 1,081 croreBharat Electronics shares are in focus following a significant Rs 1,081 crore order win, adding to previous gains. The defence PSU reported...
- India's IPO boom boosts NSE's listing business, revenue rises 12% in FY26India's booming IPO market has significantly boosted the National Stock Exchange's listing service revenue, which grew 12% to Rs 352 crore ...
- Buy, Sell or Hold: Morgan Stanley raises target price on NYKAA; Elara Capital maintains buy on Devyani InternationalBrokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...
- Should long term investors bet on Turtlemint Fintech IPO?Insurance platform Turtlemint Fintech Solutions aims to raise ₹882 crore via IPO to boost technology and working capital. Despite revenue g...
- Accenture logs $18 billion Q3 revenue, revenue misses estimatesAccenture's Q3 FY26 results revealed a slowdown in IT demand, with the company missing revenue estimates and lowering its full-year guidanc...
- Buy, Sell or Hold: Goldman Sachs remains neutral on Tata Motors; Nuvama maintains buy on HULBrokerages show selective optimism amidst market jitters. Goldman Sachs backs Shyam Metalics & Energy with a 10% upside target, anticipatin...
- Jefferies raises Polycab share price target after 30% rally in 2026. Here are 5 reasons whyPolycab India gained up to 4% after Jefferies raised its target price to Rs 10,920 and reiterated its Buy rating. The brokerage cited marke...
Load More
